The same study showed that NICD negative striatal astrocytes generated DCX/Ascl1 neuroblasts from 2 to 7 weeks after stroke, suggesting that Rbpj deletion alone was sufficient to activate their neurogenic program (Magnusson, 2014; Santopolo et al., 2020). The gene discussed is DCX; the disease is Stroke.